lnu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Cell-Antibody Interactions Studied Using HerceptinTM (trastuzumab) binding to SKOV-3 epithelial cancer cells characterized by Attana™ Quartz Crystal Microbalance Technology
Linnaeus University, Faculty of Health and Life Sciences, Department of Chemistry and Biomedical Sciences.
2013 (English)Conference paper, Poster (Other academic)
Place, publisher, year, edition, pages
2013.
National Category
Immunology
Research subject
Natural Science, Biomedical Sciences
Identifiers
URN: urn:nbn:se:lnu:diva-37247OAI: oai:DiVA.org:lnu-37247DiVA: diva2:753088
Conference
IBC's 24th Annual International Conference: Antibody Engineering & Therapeutics, December 8-12, 2013, Huntington Beach, CA
Available from: 2014-10-07 Created: 2014-09-24 Last updated: 2014-12-09Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Elmlund, Louise
By organisation
Department of Chemistry and Biomedical Sciences
Immunology

Search outside of DiVA

GoogleGoogle Scholar

Total: 15 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf